Klaipedos Nafta
KN invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the January 29th of 2021 at 9.00 am (EET). The presentation will be held in English.
The webinar will be hosted by KN Chief Executive Officer Darius Šilenskis and Chief Financial Officer Jonas Lenkšas who will introduce the performance and unaudited financial results of KN for the twelve months of 2020.
After the presentation investors are welcome to ask questions. Due to limited webinar time, we encourage participants to send their questions before the webinar until July 27th to emilija.ivanauskaite@nasdaq.com
How to join the webinar?
To join the webinar, please register via following link:
https://attendee.gotowebinar.com/register/2482896679554905103
You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can't be downloaded, a web browser which enables attending the webinar, opens automatically. The webinar will be recorded and available online for everyone at the company’s website on
www.kn.lt
and on Nasdaq Baltic youtube.com account.
What is a corporate webinar?
A corporate webinar is a virtual conference, during which company’s representatives provide information about the company and its performance. Webinar allows interactive communication and a possibility to ask questions and get answers directly from the company while being located anywhere.
Jonas Lenkšas, Chief Financial Officer, +370 694 80594.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
KH Group Oyj19.9.2025 14:20:51 CEST | Press release
Inside information: Carl Haglund appointed as CEO of KH Group Plc
F. Hoffmann-La Roche Ltd19.9.2025 14:15:00 CEST | Press release
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
Ipsen Pharma19.9.2025 13:59:15 CEST | Press release
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
Alvotech19.9.2025 13:45:00 CEST | Press release
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
Yacht Club de Monaco19.9.2025 13:11:39 CEST | Press release
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom